This prospective randomized controlled double-blind trial was performed to investigate whether glyceryl trinitrate (GTN) ointment, applied ten minutes after the removal of a eutectic mixture of local anaesthetic cream, lignocaine/ prilocaine (EMLA), influences site selection for intravenous cannulation in children. Eighty children aged between five and 15 years, having general surgery as day patients, received EMLA cream on both hands for 90 minutes prior to transfer to the theatre suite. Acting as their own controls, the children received GTN on one hand, and placebo on the other, after removal of the EMLA cream and ten minutes prior to the insertion of an intravenous cannula. The application of GTN or placebo to left or right hand was blinded and randomized.
The pain of venous cannulation is distressing for children. Several methods have been studied with the aim of reducing the pain of cannulation [1] [2] [3] . There is a considerable amount of literature supporting the safety and efficacy of the eutectic mixture of lignocaine and prilocaine (EMLA, Astra Pharmaceuticals Pty Ltd) and it has been shown to reduce venepuncture pain 4, 5, 6 . The disadvantages of EMLA include venoconstriction and expense 7 . While allowing painless cannula insertion, the venoconstrictive effects of EMLA can make the procedure technically more difficult in children who already have small veins. Glyceryl trinitrate (GTN) has been shown to cause local venous dilatation, and facilitate venous cannulation when applied topically in adults [8] [9] [10] . The use of EMLA and GTN combined has been investigated in adults and found to improve venous size, quality, and aid intravenous cannulation with no statistically significant difference in pain scores [11] [12] [13] [14] .
Only one published study was found using a combination of EMLA and GTN in children 13 . The aim of our study was to examine the influence of GTN applied for 10 minutes only at the same site after removal of EMLA, on the choice of cannulation site. In our own small pilot study on 10 adult volunteers, we demonstrated that GTN produced venodilatation when applied for 10 minutes only. We were keen to reduce the effects of systemic absorption and the likelihood of side-effects in our children and devise a clinically practical method of using this technique.
MATERIALS AND METHOD
This prospective double-blind, randomized, controlled trial was approved by the Research Ethics Committee of the Women's and Children's Hospital, Adelaide. Written informed parental consent was obtained prior to enrolment in the study. Healthy children of ASA 1 or 2 status aged five to 15 years who were scheduled for general day surgery were entered into the trial. The randomized treatment allocations were concealed from all participants including the recruiting anaesthetist until completion of the trial. A study number was allocated to each patient and demographic details and time of application of ointments noted on a data sheet by nursing staff. All children were unpremedicated and accompanied by one parent into the anaesthetic room.
The test preparations were proprietary EMLA cream, GTN ointment 2% and placebo ointment of lanolin and lactose prepared by the hospital pharmacy. The GTN and placebo ointments were supplied in coded syringes for single use only.
All children received EMLA cream, applied to the dorsum of both hands and covered with occlusive dressing, 90 minutes prior to theatre. On arrival in the theatre holding bay, the EMLA cream was completely removed from both hands of each child. GTN and placebo ointments were then applied to each of the areas that had been occupied by the EMLA cream by blinded holding bay nursing staff, who then took no further part in the study.
Children randomized to Group A received 0.05 ml of 2% GTN ointment (1 mg) applied to the right hand, and 0.05 ml of the placebo ointment to the dorsum of the left hand. Children randomized to Group B received 0.05 ml of 2% GTN ointment on the left hand and 0.05 ml of the placebo ointment on the dorsum of the right hand.
After a period of 10 minutes each child was taken into the anaesthetic room. The GTN and placebo ointments were wiped from the hands with a tissue. The specialist anaesthetists were unaware of which hand had received GTN or placebo. They were requested to examine the hands without tourniquet application and without using special techniques, such as warming hands or tapping veins, and select the hand they viewed as having the best quality veins for cannulation. The selected hand was cannulated after application of a torniquet. Where no difference in the two hands existed, anaesthetists were asked to indicate this. A record was made of the side selected for cannulation. Once cannulation had been achieved, the anaesthetist was asked to record the number of attempts required and the ease of cannu-lation (easy, mild, moderate or very difficult). Pain was assessed using a visual analog scale.
Pulse and blood pressure were recorded fiveminutely intraoperatively. In the recovery ward, pulse was recorded five-minutely and blood pressure halfhourly. Blood pressure was recorded once only on return to the Day Surgery Unit. Side-effects of headache and vomiting were specifically asked for and noted on the data sheet. Hypotension was defined as a 20% reduction in mean BP as compared with baseline on admission.
Statistical Analysis
Power analysis determined that 70 children would be sufficient to have an 80% chance of detecting a 30% difference in side chosen for cannulation. Statistical analysis was performed on the primary outcome data only using a binomial one sample differences of proportion test.
The secondary outcomes ease of cannulation, number of attempts, and pain scores with GTN and placebo were recorded but have not been compared. The relevance of the secondary outcomes is dealt with in the discussion.
RESULTS
The children were comparable in age, weight and length of application of ointments.
Of the 80 children randomized to the trial, eight were excluded because once inside the induction room, they were too anxious to have a venous cannula inserted and received inhalational induction. Of the remaining 72 children, 39 were randomized to receive EMLA and GTN to the right hand and EMLA and placebo to the left. The remaining 33 children were randomized to receive EMLA and GTN to the left hand and EMLA and placebo to the right hand. A difference in the two hands was found in all 72 cases and a cannula inserted on the side with the superior venous quality.
The GTN hand was chosen in 51 of the 72 children (70%). The probability of observing 51 or more successes in 72 binomial trials under a null hypothesis, in which the expected probability of success is only 0.5, is 0.000104. This result is highly significant (P=0.001).
The results for the secondary outcomes/number of attempts, ease of cannulation, and pain scores are expressed in terms of their own subgroup as direct comparison is not statistically valid. In cases where the GTN was selected, the hand was cannulated at the first attempt in 92% of cases and found to be easy in 84%. The mean pain score in the selected GTN hands was 2. Where the placebo hand was selected for cannulation (in 30% of patients), the hand was cannulated on the first attempt in 95% of cases, while the ease of cannulation was easy in 66% of cases. Pain scores were low (mean 1.5).
Hypotension, defined as a 20% reduction in mean blood pressure, occurred in three children (4.1%). All episodes occurred in the recovery room and resolved within a few minutes of emergence. Headache occurred in three patients; all were mild and resolved without treatment. No vomiting was recorded.
DISCUSSION
In paediatric practice, small veins combined with venoconstriction secondary to anxiety and distress may make intravenous access in children difficult. EMLA minimizes distress by providing painless or relatively painless cannulation. However the vasoconstrictive effects of EMLA that are responsible for skin blanching occur maximally after 90 minutes, often around the time the child is arriving in the operating theatre 7 . It has been demonstrated that GTN alone can be used as a topical venodilator to facilitate intravenous access in adults and children 10, 12 . More recently it has been suggested that GTN can be used as a venodilator to overcome the skin's vascular response to EMLA 11, 14 . One author has even postulated that the amount of EMLA applied may be able to be reduced when GTN is used as an adjunct, thereby increasing cost effectiveness 11 .
Our methodology was designed to assess the effect of a brief application of GTN compared with placebo on vein quality after EMLA application under normal practice conditions.
Children five to 15 years were selected for this study to avoid unnecessary exposure to GTN in the younger child, and because in our practice, children less than five years old tend to prefer gaseous induction. We also wished to avoid possible adverse effects of topical GTN in younger children who would receive a greater per kilogram dose.
An EMLA-GTN combination has been reported to influence the choice of site for cannulation, and improve ease of cannulation when compared with EMLA alone in children 13 . The methodology in that study involved the application of EMLA and GTN patches to adjacent areas of skin, to avoid contact between GTN and EMLA, since there has been some debate as to whether the presence of GTN reduces the analgesic effect of EMLA 13 . No firm evidence exists to support this theory. Two adult studies using EMLA and GTN at the same site found no statistical difference in the pain scores 11, 14 . Our methodology used GTN applied to the same site as EMLA, after the EMLA had been removed, as it had had 90 minutes to act. The analgesic effect of EMLA has been shown to increase even after removal 7 .
Our study clearly demonstrated that the side chosen for venous cannulation in a child acting as his or her own control was highly significant in the presence of GTN (P<0.001). This suggests that even a short period of exposure to GTN after EMLA removal can markedly improve conditions for cannulation.
The secondary outcomes (the number of attempts at cannulation, ease of cannulation and pain scores) are not directly comparable statistically in this study. These outcomes were assessed after the choice of hand had been made and thus the control group is not applicable for this part of the study. Those subjects where the placebo hand was selected had better appearance of the veins on the placebo hand than the GTN hand and vice versa for the subjects where the GTN hand was selected. Thus the selected placebo hands were probably not typical of all placebo hands and similarly the selected GTN hands may not have been typical of all the GTN hands. Given these limitations, it is only meaningful to compare the secondary outcomes within their own subgroup. Cannulation of both hands would be required to overcome this problem. We considered this to be unethical.
Cannulation was successful on the first attempt in the majority of patients irrespective of whether the GTN or placebo treated hand was selected. The experience and skill of the anaesthetists in cannulating children's veins may have an important influence over the ease of cannulation and number of attempts. The high success rate of the anaesthetists participating in this study (in a referral paediatric centre) cannulating with EMLA alone means that large numbers of subjects would be required to demonstrate a statistically significant improvement in that success rate with a new technique (such as application of GTN). For this reason, "choice of hand" was chosen as a more practical end-point.
There has been a reluctance to use GTN in children because of its possible side-effects including hypotension and headache. Our methodology deliberately incorporated a briefer GTN exposure time than used in previous studies to reduce the likelihood of side-effects. It has been demonstrated that there is no significant modification of haemodynamic status 30 minutes after the application of GTN ointment 0.08 mg/kg 12 . Dosage was based on the maximum dose for the youngest children in the study. Hypotension, as defined by 20% fall in systolic blood pressure, occurred in three children (4.1%). All episodes occurred early in the recovery period and may have been related to depth of anaesthesia or volume status on arrival. It is common practice in our hospital to extubate deep since our recovery ward is staffed by experienced paediatric anaesthetic nurses who are skilled in recovering patients emerging from deep anaesthesia.
Headache can occur as a side-effect of GTN, and has been reported in adult studies 11 . This may have been related to the 90 minute duration of exposure to GTN in that trial. In paediatric studies no headaches were reported with the use of GTN 12, 13 . In our study we found three children (4.1%) with headache during the recovery period. This was not statistically significant. All were mild and did not require treatment.
The clinical relevance is difficult to determine since headache has been reported as occurring postoperatively in 5.8 to 17% of adult general surgery patients (15,960 patients) 15 .
CONCLUSION
In children aged five to 15 years, GTN applied locally for a period of 10 minutes after EMLA removal significantly influences the choice of site for cannulation. This study suggests that GTN may be clinically useful as a adjunct to aiding cannulation compared to placebo in children. Further studies would be required to support its use in routine clinical practice.
